BASHAN DROR (President & CEO) purchased 68K shares of PROTALIX BIOTHERAPEUTICS, INC. on the open market
Open‑market purchase worth $102.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/13/2022ACC: 0001104659-22-045488
DirectorOfficer· President & CEO
Since Jun 2019
+68K
Net shares
Net buyer
$102.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
68K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+68K
Price / share
$1.50
Trade value
$102K
% of position
New position
4/11/2022
0.00→68K
Total
Net shares
+68K
Net value
$102K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/11/2022 | P · Purchase | +68K | $1.50 | $102K | New position | 0.00 | 68K |
| Total | +68K | $102K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.09M
Total
1.09M indirect1.09M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.09M | Indirect |
| Total | 1.09M | 1.09M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported